-
Wolchok JD
, Kluger H, Callahan MK, Postow MA, et al.
Nivolumab plus Ipilimumab in Advanced Melanoma. N Engl J Med 2013.
-
Hamid O
, Robert C, Daud A, Hodi FS, et al.
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma. N Engl J Med 2013.
-
Gansevoort RT
, Correa-Rotter R, Hemmelgarn BR, Jafar TH, et al.
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and
prevention. Lancet 2013.
-
Shaw AT
, Kim DW, Nakagawa K, Seto T, et al.
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer. N Engl J Med 2013.
|